Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoid sublingual immunotherapy.

A G Palma-Carlos1, A S Santos, M Branco-Ferreira

  • 1Clinical Allergy Immunology Center, CAIC, Lisbon, Portugal.

European Annals of Allergy and Clinical Immunology
|June 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of Cacao agroforests in the genetic conservation of Cariniana legalis, an emblematic species of the atlantic forest.

BMC ecology and evolution·2025
Same author

Elexacaftor/tezacaftor/ivacaftor, a game-changer in cystic fibrosis: The Portuguese experience.

Pulmonary pharmacology & therapeutics·2024
Same author

Ligninolytic enzyme potential of Trametes spp. associated with leaf litter in riparian forest of the Amazônia region.

Brazilian journal of biology = Revista brasleira de biologia·2024
Same author

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants.

Pulmonology·2024
Same author

Morphology of 'Crioula' guava seedlings under irrigation with increasing salinity water and nitrogen/potassium fertilization.

Brazilian journal of biology = Revista brasleira de biologia·2023
Same author

Chitosan thread in the healing of the cecal wall of rabbits (Oryctolagus cuniculus) submitted to cecorrhaphy.

Journal of biomedical materials research. Part B, Applied biomaterials·2023

Sublingual immunotherapy using monomeric allergoids offers an effective and safe treatment for allergic rhinitis. Studies show significant clinical improvements and reduced medication needs in patients with allergies to common environmental triggers.

Area of Science:

  • Immunology
  • Allergology
  • Pharmacology

Background:

  • Sublingual immunotherapy (SLIT) with monomeric allergoids is increasingly utilized in Europe.
  • Allergic rhinitis significantly impacts patient quality of life and healthcare costs.

Purpose of the Study:

  • To evaluate the efficacy and safety of sublingual monoid immunotherapy with monomeric allergoids.
  • To assess clinical outcomes and medication consumption in patients with allergic rhinitis.

Main Methods:

  • An open trial involving rhinitic patients allergic to house dust mites, grass pollens, and Parietaria was conducted.
  • A subsequent double-blind, placebo-controlled trial focused on grass pollen allergoids in hay fever patients.
  • Clinical scores, symptom severity, and medication use were primary outcome measures.

Related Experiment Videos

Main Results:

  • The open trial demonstrated clear improvements in clinical scores and reduced drug consumption.
  • The double-blind trial showed a significant decrease in rhinorrhea, sneezing, and conjunctivitis symptoms.
  • Significant reductions in nasal steroid consumption and clinical scores were observed after nasal challenges.

Conclusions:

  • Monomeric allergoid SLIT is an effective immunotherapy for allergic rhinitis.
  • This treatment approach is safe and well-tolerated in allergic rhinitis patients.
  • Sublingual immunotherapy represents a viable therapeutic option for managing allergic rhinitis.